Effects of zolpidem on sedation, anxiety, and memory in the plus-maze discriminative avoidance task

Psychopharmacology

Volumn 226, Issue 3, 2013, Pages 459-474

  Zanin, Karina A ^a   Patti, Camilla L ^a   Sanday, Leandro ^a   Fernandes Santos, Luciano ^a   Oliveira, Larissa C ^a   Poyares, Dalva ^a   Tufik, Sergio ^a   Frussa Filho, Roberto ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Consolidation; Memory; Plus maze discriminative avoidance task; PM DAT; State dependency; Zolpidem

Indexed keywords

MIDAZOLAM; ZOLPIDEM;

AMNESIA; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; LEARNING; MALE; MAZE TEST; MEMORY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEDATION; TRAINING;

ANIMALS; ANXIETY; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; DISCRIMINATION LEARNING; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPNOTICS AND SEDATIVES; MALE; MAZE LEARNING; MEMORY; MICE; PYRIDINES; TIME FACTORS;

EID: 84876475120     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-012-2756-3     Document Type: Article

References (119)

1. Alvarenga TA, Patti CL, Andersen ML, Silva RH, Calzavara MB, Lopez GB, Frussa-Filho R, Tufik S (2008) Paradoxical sleep deprivation impairs acquisition, consolidation, and retrieval of a discriminative avoidance task in rats. Neurobiol Learn Mem 90:624-632
2. American Sleep Disorder Association. Diagnostic Classification Steering Committee of the American Sleep Disorders Association (1990) International classification of sleep disorders - diagnostic and coding manual. American Sleep Disorders Association, Rochester
3. Bekinschtein P, Cammarota M, Igaz LM, Bevilaqua LR, Izquierdo I, Medina JH (2007) Persistence of long-term memory storage requires a late protein synthesis- and BDNF-dependent phase in the hippocampus. Neuron 53:261-277
4. Bekinschtein P, Cammarota M, Katche C, Slipczuk L, Rossato JI, Goldin A, Izquierdo I, Medina JH (2008) BDNF is essential to promote persistence of long-term memory storage. Proc Natl Acad Sci USA 105:2711-2716
5. Bekinschtein P, Katche C, Slipczuk L, Gonzalez C, Dorman G, Cammarota M, Izquierdo I, Medina JH (2010) Persistence of long-term memory storage: new insights into its molecular signatures in the hippocampus and related structures. Neurotox Res 18:377-385
6. Bensimon G, Foret J, Warot D, Lacomblez L, Thiercelin JF, Simon P (1990) Daytime wakefulness following a bedtime oral dose of zolpidem 20 mg, flunitrazepam 2 mg and placebo. Br J Clin Pharmacol 30:463-469
7. Berlin I, Warot D, Hergueta T, Molinier P, Bagot C, Puech AJ (1993) Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects. J Clin Psychopharmacol 13:100-106
8. Bourtchouladze R, Abel T, Berman N, Gordon R, Lapidus K, Kandel ER (1998) Different training procedures recruit either one or two critical periods for contextual memory consolidation, each of which requires protein synthesis and PKA. Learn Mem 5:365-374
9. Bruins Slot LA, Colpaert FC (1999) Opiate states of memory: receptor mechanisms. J Neurosci 19:10520-10529
10. Bruins Slot LA, Koek W, Colpaert FC (1999) Ethanol state dependence involving a lever press response requirement in rats. Behav Pharmacol 10:229-233
11. Calzavara MB, Lopez GB, Abílio VC, Silva RH, Frussa-Filho R (2004) Role of anxiety levels in memory performance of spontaneously hypertensive rats. Behav Pharmacol 15:545-553
12. Calzavara MB, Patti CL, Lopez GB, Abílio VC, Silva RH, Frussa-Filho R (2005) Role of learning of open arm avoidance in the phenomenon of one-trial tolerance to the anxiolytic effect of chlordiazepoxide in mice. Life Sci 76:2235-2246
13. Carvalho RC, Patti CC, Takatsu-Coleman AL, Kameda SR, Souza CF, Garcez-do-Carmo L, Abílio VC, Frussa-Filho R, Silva RH (2006) Effects of reserpine on the plus-maze discriminative avoidance task: dissociation between memory and motor impairments. Brain Res 1122:179-183
14. Cashman JN, Power SJ, Jones RM (1987) Assessment of a new hypnotic imidazo-pyridine (zolpidem) as oral premedication. Br J Clin Pharmac 24:85-92
15. Ceretta AP, Camera K, Mello CF, Rubin MA (2008) Arcaine and MK-801 make recall state-dependent in rats. Psychopharmacology (Berl) 201:405-411
16. Chapouthier G, Venault P (2002) GABA-A receptor complex and memory processes. Curr Top Med Chem 2:841-851
17. Chodera A, Nowakowska E, Bartczak G (1994) Tolerance to a new class of non-benzodiazepine anxiolytics. Pol J Pharmacol 46:479-481
18. Claro FT, Silva RH, Frussa-Filho R (1999) Bovine brain phosphatidylserine attenuates scopolamine induced amnesia. Physiol Behav 67:551-554
19. Colpaert FC (1986) A method for quantifying state-dependency with chlordiazepoxide in rats. Psychopharmacology (Berl) 90:144-146
20. Colpaert FC (1990) Amnestic trace locked into the benzodiazepine state of memory. Psychopharmacology (Berl) 102:28-36
21. Colpaert FC, Koek W, Bruins Slot LA (2001) Evidence that amnesic state govern normal and disordered memory. Behav Pharmacol 12:575-589
22. Crestani F, Martin JR, Möhler H, Rudolph U (2000) Mechanism of action of the hypnotic zolpidem in vivo. Br J Pharmacol 131:1251-1254
23. Crestani F, Keist R, Fritschy JM, Benke D, Vogt K, Prut L, Blüthmann H, Möhler H, Rudolph U (2002) Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors. Proc Natl Acad Sci USA 99:8980-8985
24. Cui XY, Zhao X, Chu QP, Chen BQ, Zhang YH (2007) Influence of diltiazem on the behavior of zolpidem-treated mice in the elevated-plus maze test. J Neural Transm 114:155-160
25. Danjou P, Paty I, Fruncillo R, Worthington P, Unruh M, Cevallos W, Martin P (1999) A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening. J Clin Pharmacol 48:367-374
26. Davies MF, Onaivi ES, Chen SW, Maguire PA, Tsai NF, Loew GH (1994) Evidence for central benzodiazepine receptor heterogeneity from behavior tests. Pharmacol Biochem Behav 49:47-56
27. Declerk A, Bisserbe J (1997) Short-term safety profile of zolpidem: objective measures of cognitive effects. Eur Psychiatry 1:15-20
28. Depoortere HB, Zivkovic B, Lloyd KG, Sanger DJ, Perrault G, Langer SZ, Bartholini G (1986) Zolpidem, a novel nonbenzodiazepine hypnotic I. Neuropharmacological and behavioral effects. J Pharmacol Exp Ther 237:649-657
29. Dingemanse J, Bury M, Hussain Y, Van Giersbergen P (2000) Comparative tolerability, pharmacodynamics, and pharmacokinetics of a metabolite of a quinolizinone hypnotic and zolpidem in healthy subjects. Am Soc Pharmacol Expe Ther 25:1411-1416
30. Edgar DM, Seidel WF, Gee KW, Lan NC, Field G, Xia H, Hawkinson JE, Wieland S, Carter RB, Wood PL (1997) CCd-3693: an orally bioavailable analog of the endogenous neuroactive steroid, pregnanolone, demonstrates potent sedative hypnotic actions in the rat. J Pharmacol Exp Ther 282:420-429
31. Elliot EE, White JM (2001) The acute effects of zolpidem compared to diazepam and lorazepam using radiotelemetry. Neuropharmacol 40:717-721
32. Evans SM, Funderburk FR, Griffiths RR (1990) Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability. J Pharmacol Exp Ther 255:1246-1255
33. Fahey JM, Grassi JM, Reddi JM, Greenblatt DJ (2006) Acute zolpidem administration produces pharmacodynamic and receptor occupancy changes at similar doses. Pharmacol Biochem Behav 83(1):21-27
34. Fairweather DB, Kerr JS, Hindmarch I (1992) The effects of acute and repeated doses of zolpidem on subjective sleep, psychomotor performance and cognitive function in elderly volunteers. Eur J Clin Pharmacol 43:597-601
35. Frussa-Filho R, Ribeiro RA (2002) One-trial tolerance to the effects of chlordiazepoxide in the elevated plus-maze is not due to acquisition of a phobic avoidance of open arms during initial exposure. Life Sci 71:519-525
36. Frussa-Filho R, Patti CL, Fukushiro DF, Ribeiro LTC, Kameda SR, Carvalho RC (2010) The plus-maze discriminative avoidance task: an ethical rodent model for concomitant evaluation of learning, memory, anxiety, motor activity and their interactions. In: Andersen ML, Tufik S (eds) Animal models as ethical tools in biomedic research, 1st edn. Universidade Federal de São Paulo, São Paulo, pp 364-381
37. Goldstein PA, Elsen FP, Ying SW, Ferguson C, Homanics GE, Harrison NL (2002) Prolongation of hippocampal miniature inhibitory postsynaptic currents in mice lacking the GABA(A) receptor alpha1 subunit. J Neurophysiol 88:3208-3217
38. González-Pardo H, Conejo NM, Arias JL (2006) Oxidative metabolism of limbic structures after acute administration of diazepam, alprazolam and zolpidem. Prog Neuropsychopharmacol Biol Psychiatry 30:1020-1026
39. Griebel G, Sanger DJ, Perrault G (1996a) The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (omega 1) selective, benzodiazepine receptor ligands. Psychopharmacology (Berl) 124:245-254
40. Griebel G, Sanger DJ, Perrault G (1996b) Further evidence for differences between non-selective and BZ-1 (omega 1) selective, benzodiazepine receptor ligands in murine models of "state" and "trait" anxiety. Neuropharmacology 35:1081-1091
41. Griebel G, Sanger DJ, Perrault G (1996c) The mouse defense test battery: evaluation of the effects of non-selective and BZ-1 (omega1) selective, benzodiazepine receptor ligands. Behav Pharmacol 7:560-572
42. Griebel G, Perrault G, Sanger DJ (1998) Limited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents. J Psychopharmacol 12:356-365
43. Griebel G, Perrault G, Letang V, Granger P, Avenet P, Schoemaker H et al (1999) New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes. Psychoparmacology (Berl) 146:205-213
44. Gulick D, Gould TJ (2009a) Effects of ethanol and caffeine on behavior in C57BL/6 mice in the plus-maze discriminative avoidance task. Behav Neurosci 123(6):1271-1278
45. Gulick D, Gould TJ (2009b) Interactive effects of ethanol and nicotine on learning, anxiety, and locomotion in C57BL/6 mice in the plus-maze discriminative avoidance task. Neuropharmacology 57(3):302-310
46. Gulick D, Gould TJ (2011) Nicotine acts in the anterior cingulate, but not dorsal or ventral hippocampus, to reverse ethanol-induced learning impairments in the plus-maze discriminative avoidance task. Addict Biol 16:176-188
47. Herzog CD, Gandhi C, Bhattacharya P, Walsh TJ (2000) Effects of intraseptal zolpidem and chlordiazapoxide on spatial working memory and high-affinity choline uptake in the hippocampus. Neurobiol Learn Mem 73:168-179
48. Higashima M, Kinoshita H, Koshino Y (1998) Differences in the effects of zolpidem and diazepam on recurrent inhibition and long-term potentiation in rat hippocampal slices. Neurosci Lett 245:77-80
49. Holmes A, Rodgers RJ (1999) Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze. Neurosci Biobehav Ver 23:971-980
50. Huang MP, Radadia K, Macone BW, Auerbach SH, Datta S (2010) Effects of eszopiclone and zolpidem on sleep-wake behavior, anxiety-like behavior and contextual memory in rats. Behav Brain Res 210:54-66
51. Huopaniemi L, Keist R, Randolph A, Certa U, Rudolph U (2004) Diazepam-induced adaptive plasticity revealed by alpha1 GABAA receptor-specific expression profiling. J Neurochem 88:1059-1067
52. Izquierdo I, Perry ML, Dias RD, Souza DO, Elizabetsky E, Carrasco MA, Orsingher OA, Netto CA (1981) Endogenous opioids memory modulation and state dependency. In: Martinez JL, Jensen RA, Messing RB, Rigter H, McGaugh JL (eds) Endogenous peptides and learning and memory process. Academic, New York, pp 269-290
53. Jackson A (1995) State-dependent effects of atypical benzodiazepine- receptor agonists. Psychopharmacology (Berl) 119:399-404
54. Jackson A, Koek W, Colpaert FC (1992) NMDA antagonists make learning and recall state-dependent. Behav Pharmacol 3:415-421
55. Jensen RA, Martinez JL Jr, Vasquez BJ, McGaugh J (1979) Benzodiazepines alter acquisition and retention of an inhibitory avoidance response in mice. Psychopharmacology (Berl) 64:125-126
56. Kameda SR, Frussa-Filho R, Carvalho RC, Takatsu-Coleman AL, Ricardo VP, Patti CL, Calzavara MB, Lopez GB, Araujo NP, Abílio VC, Ribeiro RA, D'Almeida V, Silva RH (2007) Dissociation of the effects of ethanol on memory, anxiety, and motor behavior in mice tested in the plus-maze discriminative avoidance task. Psychopharmacology (Berl) 192:39-48
57. Knapp DJ, Overstreet DH, Moy SS, Breese GR (2004) SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats. Alcohol 32:101-111
58. Kralic JE, Korpi ER, O'Buckley TK, Homanics GE, Morrow AL (2002) Molecular and pharmacological characterization of GABA(A) receptor alpha1 subunit knockout mice. J Pharmacol Exp Ther 302:1037-1045
59. Krystal AD, Erman M, Zammit GK, Soubrance C, Roth T (2008) Long-term efficacy and safety of zolpidemextended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep 31:79-90
60. Langtry HD, Benfield P (1990) Zolpidem: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 40:291-313
61. Leslie JC, Shaw D, McCabe C, Reynolds DS, Dawson GR (2004) Effects of drugs that potentiate GABA on extinction of positively-reinforced operant behaviour. Neurosci Biobehav Rev 28:229-238
62. Lloyd KG, Zivkovic B (1988) Specificity within the GABA receptor supramolecular complex: a consideration of the new omega 1 receptor selective imidazopyridine hypnotic zolpidem. Pharmacol Biochem Behav 129:781-783
63. Lobarinas E, Falk JL (2000) Comparison of benzodiazepines and the non-benzodiazepine agents zolpidem and zaleplon with respect to anxiolytic action as measured by increases in hypertonic NaCl-solution drinking in rats. Psychopharmacology (Berl) 149:176-180
64. Löw K, Crestani F, Keist R, Benke D, Brünig I, Benson JA, Fritschy JM, Rülicke T, Bluethmann H, Möhler H, Rudolph U (2000) Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290:131-134
65. Mathews A (1990) Why worry? The cognitive function of anxiety. Behav Res Ther 28:455-568
66. Mathiasen L, Mirza NR (2008) A comparison of chlordiazepoxide, bretazenil, L838,417 and zolpidem in a validated mouse Vogel conflict test. Psychopharmacology (Berl) 182:475-484
67. Mathiasen LS, Rodgers RJ, Mirza NR (2007) Comparative effects of nonselective and subtype-selective gamma-aminobutyric acidA receptor positive modulators in the rat-conditioned emotional response test. Behav Pharmacol 18:191-203
68. Mayo W, Dellu F, Chekaoui J, Chapouthier G, Dodd RH, Le Moal L et al (1992) Cognitive enhancing properties of beta-CCM infused into the nucleus basalis magnocellularis of the rat. Brain Res 589:109-114
69. McKernan RM, Rosahl TW, Reynolds DS, Sur C, Wafford KA, Atack JR et al (2000) Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat Neurosci 3:587-592
70. Meléndez J, Galli I, Boric K, Ortega A, Zuñiga L, Henríquez-Roldán CF, Cárdenas AM (2005) Zolpidem and triazolam do not affect the nocturnal sleep-induced memory improvement. Psychopharmacology (Berl) 181:21-26
71. Mintzer MZ, Griffiths RR (1999) Selective effects of zolpidem on human memory functions. J Psychopharmacol 13:18-31
72. Mintzer MZ, Frey JM, Yingling JE, Griffiths RR (1997) Triazolam and zolpidem: a comparison of their psychomotor, cognitive, and subjective effects in healthy volunteers. Behav Pharmacol 8:561-574
73. Mitchell CP, Ost ML, Flaherty CF (2004) Evidence for zolpidem-induced hyperphagia, but not anxiolysis, in a successive negative contrast paradigm. Pharmacol Biochem Behav 79:523-531
74. Monti JM (1989) Effect of zolpidem on sleep in insomniac patients. Eur J Clin Pharmacol 36:461-466
75. Morselli PL (1990) On the therapeutic action of alpidem in anxiety disorders: an overview of European data. Pharmacopsychiatry 23:129-134
76. Moy SS, Knapp DJ, Criswell HE, Breese GR (1997) Flumazenil blockade of anxiety following ethanol withdrawal in rats. Psychopharmacology (Berl) 131:354-360
77. Murphy HM, Ihekoronze C, Wideman CH (2011) Zolpidem-induced changes in activity, metabolism, and anxiety in rats. Pharmacol Biochem Behav 98:81-86
78. Nazar M, Jessa M, Plaznik A (1997) Benzodiazepine-GABAA receptor complex ligands in two models of anxiety. J Neural Transm 104:733-746
79. Niigaki ST, Silva RH, Patti CL, Cunha JL, Kameda SR, Correia-Pinto JC, Takatsu-Coleman AL, Levin R, Abílio VC, Frussa-Filho R (2010) Amnestic effect of cocaine after the termination of its stimulant action. Prog Neuropsychopharmacol Biol Psychiatry 34:212-218
80. Patti CL, Kameda SR, Carvalho RC, Takatsu-Coleman AL, Lopez GB, Niigaki ST, Abílio VC, Frussa-Filho R, Silva RH (2006) Effects of morphine on the plus-maze discriminative avoidance task: role of state-dependent learning. Psychopharmacology (Berl) 184:1-12
81. Patti CL, Zanin KA, Sanday L, Kameda S, Fernandes-Santos L, Fernandes HA, Andersen ML, Tufik S, Frussa-Filho R (2010) Effects of sleep deprivation on memory in mice: role of state-dependent learning. Sleep 33:1669-1679
82. Pereira JK, Vieira RJ, Konishi CT, Ribeiro RA, Frussa-Filho R (1999) The phenomenon of «one-trial tolerance» to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze is abolished by the introduction of a motivational conflict situation. Life Sci 65:101-107
83. Perrault G, Morel E, Sanger DJ, Zivkovic B (1990) Differences in pharmacological profiles of a new generation of benzodiazepine and nonbenzodiazepine hypnotics. Eur J Pharmacol 187:487-494
84. Pirker S, Schwarzer C, Wieselthaler A, Sieghart W, Sperk G (2000) GABAA receptors: immunocytochemichal distribution of 13 subunit in the adult rat brain. Neuroscience 101:815-850
85. Puia G, Vicini S, Seeburg PH, Costa E (1991) Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl - currents. Mol Pharmacol 39:691-696
86. Rodgers RJ, Cao BJ, Dalvi A, Holmes A (1997) Animal models of anxiety: an ethological perspective. Braz J Med Biol Res 30:289-304
87. Roesler R, Quevedo J, Da Silva MC, Ferreira MB, Quillfeldt JA (1997) Age-related effects of diazepam on retention of inhibitory avoidance and shuttle avoidance tasks in rats. An Acad Bras Cienc 69:89-93
88. Rowlett JK, Lelas S (2007) Comparison of zolpidem and midazolam self-administration under progressive-ratio schedules: consumer demand and labor supply analyses. Exp Clin Psychopharmacol 15:328-337
89. Rudolph U, Möhler H (2004) Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annu Rev Pharmacol Toxicol 44:475-498
90. Rudolph U, Crestani F, Benke D, Brünig I, Benson JA, Fritschy JM, Martin JR, Bluethmann H, Möhler H (1999) Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature 401:796-800
91. Salvà P, Costa J (1995) Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications. Clin Pharmacokinet 29:142-153
92. Sancar F, Ericksen SS, Kucken AM, Teissére JA, Czajkowski C (1997) Structural determinants for high-affinity zolpidem binding to GABA-A receptors. Mol Pharmacol 71:38-46
93. Sanday L, Zanin KA, Patti CL, Tufik S, Frussa-Filho R (2012a) Role of state-dependency in memory impairment induced by acute administration of midazolam in mice. Prog Neuropsychopharmacol Biol Psychiatry 37:1-7
94. Sanday L, Patti CL, Zanin KA, Tufik S, Frussa-Filho R (2012b) Amphetamine-induced memory impairment in a discriminative avoidance task is state-dependent in mice. Int J Neuropsychopharmacol. doi: 10.1017/ S1461145712000296
95. Sanger DJ, Joly D, Zivkovic B (1986) Effects of zolpidem, a new imidazopyridine hypnotic, on the acquisition of conditioned fear in mice. Comparison with triazolam and CL 218,872. Psychopharmacology (Berl) 90:207-210
96. Sanger DJ, Benavides J, Perrault G, Morel E, Cohen C, Joly D, Zivkovic B (1994) Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidence for the functional significance of receptor subtypes (review). Neurosci Biobehav Rev 18:335-372
97. Sanger DJ, Morel E, Perrault G (1996) Comparison of the pharmacological profiles of the hypnotic drugs zaleplon and zolpidem. Eur Pharmacol 313:35-42
98. Sarantis K, Sotiriou E, Papatheodoropoulos C, Matsokis N, Angelatou F (2008) Differential pharmacological properties of GABAA/benzodiazepine receptor complex in dorsal compared to ventral rat hippocampus. Neurochem Int 52:1019-1029
99. Savić MM, Obradović DI, Ugresić ND, Cook JM, Yin W, Bokonjić DR (2004) Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt. Pharmacol Biochem Behav 79:279-290
100. Savić MM, Obradović DI, Ugresić ND, Cook JM, Sarma PVVS, Bokonjić DR (2005a) Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt. Psychopharmacology (Berl) 180:455-465
101. Savić MM, Obradović DI, Ugresić ND, Cook JM, Yin W, Bokonjić DR (2005b) Bidirectional effects of benzodiazepine binding site ligands in the passive avoidance task: differential antagonism by flumazenil and beta-CCt. Behav Brain Res 158:293-300
102. Seibt J, Aton SJ, Jha SK, Coleman T, Dumoulin MC, Frank MG (2008) The non-benzodiazepine hypnotic zolpidem impairs sleep-dependent cortical plasticity. Sleep 31:1381-1391
103. Siemiatkowski M, Sienkiewicz-Jarosz H, Członkowska AI, Bidziński A, PłaÅnik A (2000) Effects of buspirone, diazepam, and zolpidem on open field behavior, and brain [3H]muscimol binding after buspirone pretreatment. Pharmacol Biochem Behav 66:645-651
104. Silva RH, Frussa-Filho (2000) The plus-maze discriminative avoidance task: a new model to study memory-anxiety interactions. Effects of chlordiazepoxide and caffeine. J Neurosci Methods 102:117-125
105. Silva RH, Frussa-Filho R (2002) Naltrexone potentiates both amnestic and anxiolytic effects of chlordiazepoxide in mice. Life Sci 72:721-730
106. Silva RH, Bellot RG, Vital MABF, Frussa-Filho R (1997) Effects of long-term ganglioside GM1 administration on a new discriminative avoidance test in normal adult mice. Psychopharmacology (Berl) 129:322-328
107. Silva RH, Felício LF, Frussa-Filho R (1999) Ganglioside GM1 attenuates scopolamine-induced amnesia. Psychopharmacology (Berl) 160:9-18
108. Silva RH, Abílio VC, Torres-Leite D, Bergamo M, Chinen CC, Claro FT, Carvalho RC, Frussa-Filho R (2002a) Concomitant development of oral dyskinesia and memory deficits in reserpine-treated male and female mice. Behav Brain Res 132:171-177
109. Silva RH, Kameda SR, Carvalho RC, Rigo GS, Costa KLB, Taricano ID, Frussa-Filho R (2002b) Effects of amphetamine on the plus-maze discriminative avoidance task in mice. Psychopharmacology (Berl) 160:9-18
110. Silva RH, Chehin AB, Kameda SR, Takatsu-Coleman AL, Abílio VC, Tufik S, Frussa-Filho R (2004) Effects of pre- or post-training paradoxical sleep deprivation on two animal models of learning and memory in mice. Neurobiol Learn Mem 82:90-98
111. Sun C, Sieghart W, Kapur J (2004) Distribution of alpha1, alpha4, gamma2, and delta subunits of GABAA receptors in hippocampal granule cells. Brain Res 1029:207-216
112. Tang AH, Smith MW, Carter DB, Im WB, Von Voigtlander PF (1995) U-90042, a sedative/hypnotic compound that interacts differentially with the GABA-A receptor subtypes. J Pharmacol Exp Ther 275:761-767
113. Vargas-Caballero M, Martin LJ, Salter MW, Orser BA, Paulsen O (2010) Alpha5 subunit-containing GABA(A) receptors mediate a slowly decaying inhibitory synaptic current in CA1 pyramidal neurons following Schaffer collateral activation. Neuropharmacology 58:668-675
114. Visser SA, Wolters FL, van der Graaf PH, Peletier LA, Danhof M (2003) Dose-dependent EEG effects of zolpidem provide evidence for GABA(A) receptor subtype selectivity in vivo. J Pharmacol Exp Ther 304:1251-1257
115. Wesensten NJ, Balkin TJ, Belenkey GL (1996) Effects of daytime administration of zolpidem and triazolam on performance. Aviat Space Environ Med 67:115-120
116. Wichlinski LJ, Jensen RA (1996) Effects of beta-CCE on retention of aversively- and appetitively-motivated tasks in rats. Physiol Behav 60:1121-1124
117. Yee BK, Hauser J, Dolgov VV, Keist R, Möhler H, Rudolph U, Feldon J (2004) GABA receptors containing the alpha5 subunit mediate the trace effect in aversive and appetitive conditioning and extinction of conditioned fear. Eur J Neurosci 20:1928-1936
118. Zanin KA, Patti CL, Tufik S, Poyares D, Frussa-Filho R (2011) Zolpidem impairs non-associative memory in mice. Sleep Sci 3:81-87
119. Zivkovic B, Perrault G, Morel E et al (1988) Comparative pharmacology of zolpidem and other hypnotics and sleep inducers. In: Sauvanet JP, Langer SZ, Morselli PL (eds) Imidazopyridines in sleep disorders: a novel experimental and therapeutic approach. Raven, New York, pp 97-109